Main Session
Sep 30
SH 05 - Genitourinary Cancer - Science Highlights

7 - Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003

08:10am - 08:15am ET
Room 109

Presenter(s)

Mark Buyyounouski, MD, MS, FASTRO Headshot
Mark Buyyounouski, MD, MS, FASTRO - Stanford University, Stanford, CA